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Abstract
Variations in gene expression level might lead to phenotypic diversity across individuals or populations. Although many
human genes are found to have differential mRNA levels between populations, the extent of gene expression that could
vary within and between populations largely remains elusive. To investigate the dynamic range of gene expression, we
analyzed the expression variability of ,18, 000 human genes across individuals within HapMap populations. Although
,20% of human genes show differentiated mRNA levels between populations, our results show that expression variability
of most human genes in one population is not significantly deviant from another population, except for a small fraction that
do show substantially higher expression variability in a particular population. By associating expression variability with
sequence polymorphism, intriguingly, we found SNPs in the untranslated regions (59 and 39UTRs) of these variable genes
show consistently elevated population heterozygosity. We performed differential expression analysis on a genome-wide
scale, and found substantially reduced expression variability for a large number of genes, prohibiting them from being
differentially expressed between populations. Functional analysis revealed that genes with the greatest within-population
expression variability are significantly enriched for chemokine signaling in HIV-1 infection, and for HIV-interacting proteins
that control viral entry, replication, and propagation. This observation combined with the finding that known human HIV
host factors show substantially elevated expression variability, collectively suggest that gene expression variability might
explain differential HIV susceptibility across individuals.
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Introduction
In both prokaryotic and eukaryotic organisms, variations in
gene expression exist widely within and between populations,
which can be attributed to either genetic or non-genetic factors.
Genetic factors are changes in DNA sequence that cause
expression differences, such as single nucleotide polymorphisms
(SNPs) and copy number variations (CNVs) on expression
qualitative trait loci (eQTLs) [1,2]. Non-genetic factors include
epigenetic modifications [3,4] and also innate expression stochas-
ticity at the single-cell level [5,6]. To date, extensive studies have
investigated gene expression variation within and between natural
populations of yeast [7,8], fly [9–11], fish [12–14] and human
[1,2,15–17]. These studies were mostly focused on identifying
genes showing differential expression between populations or on
localizing causal elements that affect expression changes among
individuals (eQTL mapping). However, expression variation, as a
manifested phenotype, in and of itself has complicated functional
implications. It is established that the onset of many human
diseases was associated with expression variation of some crucial
genes [18,19], and therefore gene expression variation is likely to
be subject to selection. In this sense a systematic study on the
expression variability within human populations is needed, which
delineates the dynamic range of gene expression, i.e. to what
degree a gene’s expression could vary across individuals. This is of
particular importance for several reasons. First, expression variability
is conceptually distinct from differential expression (difference in mean
expression level between populations); therefore studying expression
variability might shed light on the evolution and differentiation of
human gene expression. In analogy to sequence evolution, if a new
advantageous expression level is rapidly fixed by natural selection
in one population, a substantial reduction in expression variability
might be expected. Second, expression variability is a natural
estimate of dosage sensitivity of human genes. Due to natural
selection, expression variability of dosage-sensitive genes is
expected to be minimized; therefore investigation of expression
variability might pave the way to future study of dosage sensitivity
for human genes. Finally, recent genome-wide association studies
have been based on the hypothesis of common disease-common
variant (often abbreviated CD-CV), which carries the assumption
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of disease-associated genes, giving rise to pathological phenotypes.
Given the widespread differential susceptibility to diseases within
human populations, by circumventing the identification of causal
sequence variants, a direct examination of expression variability of
human genes and its implication towards disease susceptibility
would highlight the importance of associating expression poly-
morphism to human disease.
In this paper, we sought to tackle the above questions by
investigating the expression variability of human genes based on
the previously published whole-genome expression profiling data
[1,2]. We found that, for most human genes, their within-population
variability does not significantly differ between populations, with
only a small group of genes exhibiting population-specific
expression variability. Furthermore, this set of variable genes has
SNPs in their untranslated regions (both 59 UTRs and 39UTRs)
that show a pronounced elevated difference in population
heterozygosity, which might explain, at least partially, their
deviant expression variability between populations. We also found
that a majority of human genes shows substantially reduced
within-population variability, prohibiting the genes from differen-
tial expression between populations. Functional enrichment
analysis revealed that genes with higher within-population
variation are involved in a number of human diseases, particularly
the early stage of HIV-1 entry into target cells, suggesting that
expression variability is linked to variation in susceptibility to HIV
infection among individuals.
Results
The expression variability of most human genes is
consistent between populations
The recently released whole-genome expression profiling data
include 270 HapMap individuals spanning 4 ethnic populations
[1,2], including CHB (Chinese Han in Beijing), YRI (Yoruba
people of Ibadan, Nigeria), CEU (U.S. residents with northern and
western European ancestry) and JPT (Japanese from Tokyo). After
preprocessing the expression data, we compiled expression profiles
of 18, 081 human mRNA transcripts across all HapMap
populations (CEU/YRI unrelated children, CEU/YRI unrelated
parents, CHB and JPT, see Materials and Methods). After
filtering out the Y-linked genes, we included both male and female
samples since sex-biased expression is minimal (even for X-linked
genes) in the lymphoblastoid cell line [20]. Although the
subsequent analysis was based on CEU and YRI adult children
(30 individuals in each population), all the conclusions hold for
CEU/YRI parents, and also CHB and JPT, unless otherwise
mentioned (see Figures S1, S2, S3, S4, S5).
We first sought to examine whether these genes have similar
level of within-population variability in different populations. For
each gene, we quantified the within-population expression
variability by calculating its coefficient of variation g, which is
the ratio of the standard deviation of its expression (across 30
individuals within a population) to the mean value [21–23].
Although other metrics can be used to quantify the expression
variability, g is known to be one of the most robust and unbiased
metrics [21]. Greater g implies higher expression variability for a
particular gene across individuals within a population, while a
significant reduction in g suggests that the gene might be dosage
sensitive and thus under severe selection to minimize expression
variability. The g values were calculated for each of the 18,081
mRNAs across individuals within the CEU and YRI populations
separately (see Table S1 for genes with their calculated expression
variability in each population). Between the CEU and YRI
populations, most of the human genes exhibit a similar level of
within-population variability, as g in CEU is well correlated with
that in YRI (r=0.88, P<0; Figure 1). Pair-wise comparison of
expression variability between all HapMap populations further
confirmed this trend (r.0.85, P<0). The same trend was
recapitulated on another independent dataset of smaller sample
size based on Affymetrix Human Focus Arrays [16], suggesting
this observation was not resultant from a technical artifact.
Therefore such a strong correlation of within-population expres-
sion variability between the two populations suggests either
expression variability of most genes is subject to similar levels of
constraints in both populations, or the cis- or trans- regulatory
mechanisms of these genes have not diverged significantly.
Figure 1. Correlation of expression variability between CEU
and YRI populations. Each data point represents one transcript.
doi:10.1371/journal.pcbi.1000910.g001
Author Summary
Many human genes have population-specific expression
levels, which are linked to population-specific polymor-
phisms and copy-number variations. However, it is unclear
whether human genes show similar dynamic range of
expression between populations. In this work we analyzed
HapMap gene expression compendium, and quantified the
between-population and within-population expression
variability for ,18,000 human transcripts. We first con-
cluded that the majority of the human genes have similar
levels of within-population variability. However, a small
fraction (,4%) does show much higher expression
variability in one population, and the deviation is
consistently associated with increased SNP heterozygosity
in their UTR regulatory regions. We further showed that
genes with the greatest within-population expression
variability are significantly enriched for chemokine signal-
ing associated with HIV-1 infection. Combined with the
finding that human HIV-1 host factors tend to have
increased expression variability within populations, our
analysis may explain, at least in part, different susceptibility
to HIV infection within the human population. This work
provides a fresh angle for analyzing gene expression
variations in populations.
Gene Expression Variation and Human Diseases
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genes are tightly correlated between populations, a small number
of genes do show noticeably different level of variability between
CEU and YRI (Figure 1). To systematically identify those outliers
with population-specific expression variability, we reciprocally
regressed the values of g based on a linear model with random
effects. Using residual analysis (see Materials and Methods)w e
were able to identify 919 and 898 genes as outliers for g’s in YRI
and CEU respectively as the explanatory variables. Among these
outlier genes, 711 were found to be independent of the direction of
the regression (either regressing gCEU with gYRI or regressing
gYRI with gCEU, see Table S2 for a complete gene list). We
noticed the presence of some annotated SNPs on the Illumina
probes (affecting 4.5% of the 711 variable genes), so we removed
the affected genes and only considered the remaining 679 outlier
genes in our following analysis. We also noted that, among all the
human genes, about 5% (916/18,081) had a probe overlapping
with SNPs; this percentage is statistically indistinguishable from
the percentage for the outlier genes (5% vs 4.5%, P-value=0.50,
Chi-square test). We thus eliminated the possibility that the
observed expression variability was caused by the existence of
SNPs in the microarray probes.
Cis-SNPs on UTRs of variable genes show elevated
difference in population heterozygosity
Could the observed asymmetric expression variability between
populations be explained by their associated sequence variants?
Supposing expression of a gene is only affected by a causative bi-
allelic SNP, it is expected that the SNP with similar minor allele
frequencies (MAFs) in both populations should have comparable
expression variability of the associated gene. In other words, the
observed increased expression variability of a particular gene is
likely to be associated with some causative SNPs with divergent
MAFs between two populations. Particularly under the assump-
tion of Hardy-Weinberg Equilibrium for the diploid human
populations, MAF of a SNP can be used to infer its expected
heterozygosity h (fraction of the heterozygous genotype) within a
population [24]. Thus if a gene shows elevated expression
variability in one population, the sequence variants affecting this
gene are likely to have elevated expected heterozygosity within the
population. Due to the difficulties in identifying trans-acting
factors, we set out to examine this possibility for cis-SNPs
surrounding the 679 genes showing population-specific expression
variability.
We downloaded the promoter, 59 UTR and 39 UTR sequences
for all human RefSeq genes (.20, 000) from UCSC Genome
Browser [25], and mapped ,3 million HapMap Phase II SNPs
onto them (see Materials and Methods). We first examined the
SNPs on 59UTRs. We divided the 679 most variable genes into
two groups: genes showing higher expression variability in CEU
(383/679, termed CH group), and the remaining genes (296/679)
showing higher expression variability in YRI (termed YH group).
With the current SNP annotation, we were able to map SNPs onto
the 59 UTRs of 5, 690 human genes, including 130 CH genes and
94 YH genes. For each SNP on the CH genes, we calculated its
difference in expected population heterozygosity between CEU
and YRI (Dh
CEU{YRI
CH ), and the same calculation was performed
for all the SNPs on all the mapped 5, 690 human genes as
background control (Dh
CEU{YRI
background ). As CH genes show elevated
expression variability in CEU than in YRI, by comparing with
genome background, we next tested if they are enriched for genes
associated with higher population heterozygosity in CEU than in
YRI (Dh
CEU{YRI
CH w0). As each gene often has multiple SNPs on its
59UTRs, we first selected a cutoff, k, varying from 0 to 0.5 (the
maximal Dh) with an increment of 0.04, and then compared the
percentage of genes in each group (CH genes and background
genes) bearing at least one SNP with Dh
CEU{YRI greater than this
cutoff. As seen in Figure 2(A), for all the cutoffs used, the CH
genes consistently showed higher percentage than the genome
background. To determine the statistical significance, we chose to
use a stringent cutoff k=0.04 (instead of using k=0 to avoid
numerical fluctuation), and found the percentage of genes in CH
group bearing at least one SNP with Dh
CEU{YRI.k is significantly
higher than the genome background (P=3.4610
23, x
2 test).
Similarly for YH genes, population heterozygosity was compared
between YRI and CEU; thus Dh
YRI{CEU
YH and Dh
YRI{CEU
background were
calculated for each YH SNPs. With the same analysis, as shown in
Figure 2(B), we reached the same conclusion that YH genes are
significantly enriched for genes with elevated population hetero-
zygosity in YRI (P=0.05, x
2 test).
For 39 UTR SNPs, we found the same enrichment for CH
genes (P=1.5610
23, x
2 test), but not for the YH genes (P=0.8, x
2
test). Moreover, neither CH nor YH genes show the trend on
promoter SNPs (P.0.3, x
2 test). Taken together, the observed
unequal expression variability between populations is likely to be
explained, at least in part, by uneven MAF and population
heterozygosity of the SNPs on UTR regions.
Among the 679 outlier genes that showed population-specific
expression variability (see above), we were able to identify 184
genes that have differentiated expression levels between CEU and
YRI (FDR#0.01, 10,000 random permutations) after Benjamini
and Hochberg FDR correction (see Materials and Methods),
i.e. these genes on average have significantly higher expression
levels in one population than in the other. For each of these 184
transcripts, we then plotted the distribution of within-population
expression variabilities in CEU and YRI as a histogram in
Figure 3, where the red diagonal line on the horizontal plane
indicates equal expression variability in both CEU and YRI.
Strikingly, we found among the total 184 transcripts, far more
genes had higher expression variability in YRI (105 genes, 57%)
than in CEU (79 genes or 43%). As we described in the above
sections, among the total 679 outlier genes, 44% had higher
expression variability in YRI, while among the 184 differentially
expressed genes, a subset of the 679 outlier genes, the percentage
substantially increased to 57%. With 10, 000 random permutation
test, we confirmed such an enrichment of genes with higher
expression variability in YRI is highly significant (P,10
25).
Although the conclusion was drawn from 30 unrelated adult
children from CEU and YRI, it also holds for the 60 unrelated
parents in the two populations, suggesting our results are robust
against sample size.
Reduced gene expression variability between
populations
Among the majority of genes that have similar within-
population expression variability in CEU and YRI (the non-
outlier genes, see Materials and Methods), we also detected
,20% (3, 429) that show differential expression levels between
these populations with FDR=0.01 (Benjamini and Hochberg
FDR correction). Combined with the fact that only 184 among the
679 outlier genes (27%) show differential expression levels (see the
above section), this clearly suggests the divergence of gene
expression between populations is mostly manifested as a
significant shift in expression levels without affecting within-
population variability. We further quantified the degree of
differential expression for each transcript between CEU and
YRI through t-scores derived from a standard t-test (see
Materials and Methods), which is the standardized distance
Gene Expression Variation and Human Diseases
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absolute value of t-score is equivalent to a lower p-value, e.g.
t=62 corresponding to p=0.05 before Bonferroni correction,
and t=65 corresponding to p=0.05 after Bonferroni correction.
As expression variability between CEU and YRI is almost
perfectly correlated after removing the outliers in this study
(r=0.94), we only compared t-scores and expression variability for
the transcripts in CEU (Figure 4, in which we used t=64a sa
threshold to define differential expression levels between the
populations, indicated by the two vertical lines, approximately
corresponding to p=2610
24). As shown in Figure 4, a majority
of genes has t-scores centered on 0 and has substantially reduced
within-population expression variability compared with the
genome background (the horizontal line). This observation
indicates that a significant reeducation in expression variability
within a population prohibits the genes from differential
expression between populations. This group of genes is likely to
be dosage-sensitive, which requires them to have similar
expression levels between populations. It is also clear from
Figure 4 that some genes have similar expression levels between
two populations but also have very high expression variability
(above the horizontal line); this implies these genes might be more
dosage tolerant. We further noted a significant positive correlation
between t-score and expression variability (r=0.18, P,0.01) for
Figure 2. Genes that have higher within-population expression variation have higher expected heterozygosity than genome
background. (A) Comparison of expected heterozygosity between background genes and CH genes. For each group we calculated the percentage
of genes having at least a SNP in its 59UTR with Dh
CEU-YRI greater than a given cutoff, k, varying from 0 to 0.5 (the maximal Dh
CEU-YRI) with an increment
of 0.04, which gives 13 bins. (B) Comparison of expected heterozygosity between background genes and YH genes. For each group we calculated the
percentage of genes having at least a SNP in its 59UTR with Dh
YRI-CEU greater than a given cutoff, k, varying from 0 to 0.5 (the maximal Dh
YRI-CEU) with
an increment of 0.04, which gives 13 bins.
doi:10.1371/journal.pcbi.1000910.g002
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expression variability are more likely to develop more divergent
expression levels between populations. Thus high expression
variability is likely to confer higher expression evolvability. The
conclusion stands when using another approach to identify the
differentially expressed genes, which considers potential batch
effects at the establishment of the cell lines [2].
Genes with the highest within-population expression
variability are linked to disease susceptibility
Next we sought to determine whether genes with extreme within-
population variability are specifically involved in any maladaptive
processes. Since we are now studying the global trend of expression
variabilityofhumangenes,we sought to exclude thegenesthat have
population-specific expression variabilities. We excluded 1,106 of
such genes from the total list of 18, 081 genes by either regressing
gCEU with gYRI or regressing gYRI with gCEU (the union set,
compared with the outliers as intersection set described above). In
the end we retained a total of 16,975 mRNAs that showed similar
variability in CEU and YRI. Since these transcripts have highly
correlated within-population variability between these two popula-
tions, we focused the following analysis only on CEU population,
unless otherwise mentioned.
The 16,975 mRNAs with homogeneous variability in the two
populations were ranked according to their expression variability
g from the lowest to the highest. By controlling the confidence
level at 5%, we selected the top 2.5% and bottom 2.5% as the
most and the least variable genes for further comparison
respectively (424 out of 16, 975 genes for each group, see Table
S3 for complete lists of genes). We performed an enrichment test
by setting all 16, 975 transcripts in our study as background, then
applied subsequent false discover rate (FDR) correction on each
functional category using classifications in the DAVID biological
database [26]. Functional enrichment analysis specifically included
(1) Gene Ontology (GO) classifications (biological process, cellular
component and molecular function at all levels), (2) KEGG
pathways, (3) interaction with HIV-1 (human immunodeficiency
virus 1) (from NCBI HIV-1, Human Interaction Database [27]), and (4)
human disease annotations (from NIH Genetic Association
Database [28] and OMIM).
As shown in Table 1, genes with the lowest expression
variability are significantly enriched for fundamental biological
processes such as translation and ribosome constituents (FDR=0.02).
The ribosomal genes are known to be dosage-sensitive [29]; this
observation strongly suggests that expression variability within
Figure 3. The distribution of expression variability for the 184 differentially expressed genes. The red diagonal line on the horizontal
plane is a reference line, indicating equal expression variability in both populations.
doi:10.1371/journal.pcbi.1000910.g003
Figure 4. 2D histogram of t-scores between CEU and YRI and
expression variation in CEU. Only genes with variability smaller than
0.05 (15, 932 out of 16,878) are presented here. The two vertical lines
are thresholds defining differential expression (up- and down-
regulation) and the horizontal line indicates expression variability of
genome background, which is the median across all the surveyed
transcripts.
doi:10.1371/journal.pcbi.1000910.g004
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human genes. In sharp contrast with the least variable genes, genes
with the greatest variability are enriched for behavior (FDR=0.08),
taxis (FDR=0.02) and response to external stimulus (FDR#0.05).
While genes with the least expression variability are not associated
with any human diseases reported from case-control studies
deposited in GAD (NIH Genetic Association Database [28]),
interestingly, genes with the highest expression variability are
associated with seven human diseases (Table 1), mostly related to
disease classes including ageing (FDR=0.007) and neurological
disorders (FDR=0.036). Examination using disease associations
documented in OMIM (Online Mendelian Inheritance in Man)
did not find significant associations, however this might be due to
the lower coverage of OMIM as compared to GAD, and the more
stringent criteria used by OMIM in reporting disease associations.
As GAD is primarily designed for collecting disease-associated
genes bearing unevenly distributed biomarkers (e.g. SNPs), our
observed disease association might be attributed to expression
manifestation of these documented sequence polymorphisms.
Gene expression variability and HIV infection
In addition to being enriched for disease annotations listed
above, genes with the highest expression variability also show
significant enrichment for interaction with two HIV-1 proteins (see
Materials and Methods). Notably, the highly variable genes
are associated more frequently with the HIV-1 gene env (the
precursor to HIV surface glycoprotein gp120; FDR=0.018), and
preferentially up-regulate the other HIV-1 gene, tat
(FDR=0.0024), whose protein product is of vital importance in
regulating viral replication. Worthy of note, the HapMap samples
used in this study were derived from lymphoblastoid B cells while
the natural targets of HIV-1 are CD4
+ T cells; however recent in
vitro experiments have established that the lymphoblastoid cell line
derived from B cells can well reflect the behavior of CD4
+ T cells
upon the infection of HIV-1 [30]. Therefore our observations
suggest that the variation among individuals in their susceptibility
to HIV viral entry or replication might be linked to the elevated
expression variability of the host genes interacting with env and tat.
Further lending support to this hypothesis, we found that variable
genes are also enriched for chemokine receptors (FDR=0.08).
Since the HIV-1 virus fuses into target cells mainly through
interactions between gp120 and chemokine receptors (e.g.
CXCR4 and CCR3), this strongly supports that variability across
populations is inherently linked to varied susceptibility to HIV-1.
The HIV-1 genome consists of 9 genes: env, gag, nef, pol, rev, tat,
vif, vpr and vpu. To further explore the strong association between
expression variability of host genes and HIV-1 pathogenesis, we
next compared the expression variability of human host factors
interacting with each of the 9 viral genes against human genome
background (for CEU and YRI separately). The host-virus
interactions were extracted from HIV-1, Human Protein Interaction
Database [27]. We were able to identify 700, 194, 235, 211, 73,
853, 83, 215 and 30 human transcripts in our data set that have
annotated interactions with the 9 HIV-1 genes respectively, and
we examined the interactions in all categories (e.g. physical
interaction, up-regulate or down-regulate, etc.). Strikingly, for 5 of
the 9 HIV-1 genes (env, gag, nef, tat and vpr), the host factors
exhibited significantly elevated expression variability in both
populations (all p-values,0.05, Wilcoxon ranksum test;
Figure 5a). For rev (regulator of virion) and vpu (viral protein
U), only YRI population exhibited elevated expression variability
(note that the relatively large error bars for vpu in both populations
were due to small sample size as only 30 human genes were
annotated to interact with vpu).
Table 1. Enriched functional categories for genes showing the least and the most expression fluctuation (FDR,0.1).
GO-Biological Process GO-Cellular Component GO-Molecular Function Disease Association
Genes showing the
least expression variability
neuropeptide signaling pathway cytosolic ribosome constituent of ribosome
neurological system process ribosomal subunit transmembrane
receptor activity
translation large ribosomal subunit rhodopsin-like
receptor activity
multicellular organismal process small ribosomal subunit molecular transducer activity
cell surface receptor
linked signal transduction
plasma membrane
Genes showing the
most expression variability
anatomical structure
morphogenesis
plasma membrane integrin binding hepatocellular carcinoma
chemotaxis integral to Golgi membrane receptor binding osteoarthritis
immune response cytoskeletal protein binding psoriasis
cell morphogenesis chemokine activity heart disease, ischemic
behavior chemokine receptor binding asthma
locomotory behavior cytokine binding skin cancer,
non-melanoma
cell communication Q fever
cytosolic calcium ion homeostasis
response to external stimulus Associated Disease
Class
aging
neurological
doi:10.1371/journal.pcbi.1000910.t001
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lymphoblastoid cell line (an immune-related cell line that HIV
virus can attack), combined with the observation that genes
involved in immune system are enriched among the host factors
interacting with the viral genes (P-value,0.05), it is tempting to
trivially explain the above observation by the intrinsic variability of
immunity genes [31–33]. To ascertain this possibility, we identified
361 human transcripts (,16% of all the host factors in this study)
that contain the keyword ‘‘immune’’ in their Gene Ontology
annotations (Biological Processes, all hierarchies), and removed
them from the host factors and repeated the above comparison.
Again, we found host factors interacting with nef (negative
regulatory factor), tat (trans-activator of transcription) and vpr
(viral protein R) constantly show elevated expression variability in
both CEU and YRI, which suggests that the elevated expression
variability of the host genes cannot be fully explained by the
enrichment of the immunity genes.
After ruling out the effect of immunity genes, we next applied
two approaches to ascertain the possibility that the elevation of
expression variability for HIV-interacting genes could be due to
enrichment of highly variable GO functional categories. (i) Firstly,
we pooled together the entire 1, 480 human genes that were
annotated to interact with at least one HIV-1 genes, and removed
551 genes associated with the highly variable functions (based on
GO terms derived from Table 1 and Supplemental Table S4, we
removed all genes associated with these GO terms and their
descendents in the GO hierarchy). For the remaining 929 HIV-
interacting genes, again we observed their within-population
expression variability is significantly higher than genome back-
ground in both CEU and YRI (showing ,17% increase in
Figure 5. Human genes involved in HIV infection have higher expression variability. (A) Human genes interacting with HIV proteins show
elevated expression variability. P-values less than 0.05 are indicated by asterisks. Error bars are 95% confidence intervals derived from 5, 000 bootstrap
re-sampling. (B) Key factors affecting HIV susceptibility in literature show elevated expression variability compared with that of the genome
background.
doi:10.1371/journal.pcbi.1000910.g005
Gene Expression Variation and Human Diseases
PLoS Computational Biology | www.ploscompbiol.org 7 August 2010 | Volume 6 | Issue 8 | e1000910comparison with expression variability of all human genes,
P,10
211, Wilcoxon ranksum test). (ii) In the second approach,
we generated ‘‘null’’ sets of genes, mirroring the GO functional
categories of the 1,480 HIV-1 interacting genes and compared the
variability of these null sets to the real gene set. Among the 1, 480
genes, we were able to consider 1, 284 genes, whose GO
annotations (the most specific code) were also associated with at
least one non-HIV interacting gene. We then chose a non-HIV-
interacting gene with the same GO code and repeated this for
every one of the 1,284 genes to make a null set. We repeated this
procedure 1000 times by generating 1000 null gene sets, and asked
among the 1000 simulations, how many times we observe the real
data have significantly higher expression variability than the null
set. Consistently, we found in all simulations, the real data always
have average higher expression variability (on average 8% higher),
and 991 out of the 1000 simulations are statistically significant.
Thus we concluded that the observed elevation in expression
variability of HIV-interacting genes is unlikely an artifact caused
by the bias in the GO functional annotations.
Next we curated a list of human genes from the published
literature that are known to induce differential susceptibility to
HIV, and compared their expression variability with the
genomic background. These genes included chemokine receptors
(CCR2 [34–36], CXCR4 [37]), HIV-suppressive b-chemokines
(CCL3 [38], CCL3L1 [39], CCL4 [40], CCL5 [41,42],
CXCL12 [43,44]), a human endogenous HIV-1 replication
inhibitor known to be involved in the mid stage of viral
propagation (APOBEC3G [45]), and a newly identified inducible
host factor implicated in the late stage of HIV-1 replication
pathway (SOCS1) [46]. As shown in Figure 5(b), these key host
factors have substantially elevated expression variability as
compared to the genomic background. For example, CXCR4,
one of the major chemokine receptors, has an almost 4.3-fold
increase in expression variability, suggesting that it might have
extremely low expression level in some individuals, leading to
increased resistance to HIV entry (particularly for X4 strain,
which utilizes CXCR4 for viral entry). Although we did not
observe significantly elevated expression variability for CCR5
(g=0.02, slightly higher than the genome background), we
indeed found its ligand CCL3L1 had a 3-fold increase in
expression variability. This is consistent with the previous
observation that increased copy number of CCL3L1 in some
individuals can effectively reduce the risk of HIV-1 infection
[39]. Similarly, CXCL12 (SDF-1), the ligand of CXCR4, has a
4.4-fold increase in expression variability. These results collec-
tively bolster the hypothesis that variation in genetic expression
within a population may result in altered susceptibility to HIV-1
infection.
We further compared our results with a recent work by Loeuillet
et al [30], in which the authors established a link between a SNP
(rs2572886) to differential HIV susceptibility among European
individuals by transduction of lymphoblastoid cells (the same cell
line used in our study) with a HIV-1-based vector (HIV.GFP). The
identified SNP is associated with 8 genes belonging to the LY6/
uPAR family, and the authors prioritized 4 proteins (LYP6D,
LYPD2, SLURP1 and GML) for over-expression study and 2
proteins (LY6D and LYPD2) for RNAi knockdown. However the
authors did not observe HIV infectivity being significantly affected
by these perturbations [30]. We re-examined expression variability
among CEU individuals for these prioritized proteins, and found
their expression variability is substantially below genome average
(between 0.009–0.01, compared with the genome median of
,0.0197). Among the remaining 4 tagged genes that were not
examined in the original study, LY6E showed almost ,1.8–2.5-
fold increase in expression variability in comparison with that of
background genes (expression variability of LY6E is 0.049 and
0.035 in CEU and YRI, respectively, in comparison with the
background median of ,0.0197). Therefore a re-examination of
LY6E might be needed in future studies to elucidate the roles of
this gene in affecting HIV susceptibility.
Discussion
Although extensive efforts have been made to elucidate the
effects of sequence variants on expression phenotypes, it is likely
that not all expression variation can be fully explained by genetic
factors [1,47]. As gene expression is more pertinent to molecular
functions, exploration of expression variability within and between
human populations could provide additional insights into
functional evolution of human genes. Unlike previous work that
had focused on finding genes that are differentially expressed
between populations [15,16,48,49] or mapping eQTLs [17,47],
throughout this paper, we quantified expression variability for
each human gene within individual human populations, and
attempted to interpret the functional and evolutionary implica-
tions of such variations.
Our results revealed that the evolution of differential expression
in human is largely manifested as a shift in mean expression level
between populations without affecting their respective expression
variability in each population. As within-population expression
variability could be used to approximate dosage-sensitivity of a
given gene, our observation also suggests that dosage-sensitivity of
human genes is largely conserved between human populations.
We also found that differentially expressed genes are more likely to
have higher expression variability, which suggests variability might
confer higher evolvability due to relaxed constraints.
For those genes that do have significantly different variability
between distinct populations (referred as outliers), we also observed
dissimilar minor allele frequencies (and thus population heterzyg-
osity) between CEU and YRI in their UTRs, particularly on the
59UTRs. It is possible that in addition to the cis-regulatory regions,
other trans-acting and non-genetic factors might also take effect.
Our analysis revealed that genes with the highest expression
variability within human populations are significantly associated
with a number of human diseases, which may account for the
differential susceptibility to diseases among human individuals.
Although it is expected that sequence polymorphisms tend to be
associated with elevated expression variability, other factors such
as copy number variations (CNV) and epigenetics, could also
cause variation in gene expression level. To this end, we compiled
a list of ,1, 800 RefSeq genes that reside in CNV regions
identified from a recent fine-resolution mapping with pair-end
sequencing [50]; however, we did not find the genes showing the
highest expression variability are enriched for CNV genes. At the
present time, it is difficult to separate the epigenetic effects from
genetic effects based on available data, but it is important to note
that epigenetic diversity across individuals and among populations
can have profound impact in expression variability.
It has long been noted that susceptibility to HIV infection differs
greatly among individuals, and individuals infected with HIV also
have substantially varied rate of disease progression to full-blown
AIDS. To explain such variation in viral resistance, several
sequence variants of human genes have been identified, which is
best exemplified by CCR5-D32 deletion [51,52] and CCL3L1
copy number variants [39]. By circumventing the identification of
the associated sequence variants, our analysis on gene expression
posed an important question in understanding the differential HIV
susceptibility, i.e. whether examining expression polymorphisms
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possibility, i.e. host factors interacting with several HIV genes,
controlling viral entry, progression and replication cycles, show
substantially elevated expression variability among individuals.
Interestingly, although host factors involved in immune system are
major targets in current HIV research, our results also
demonstrated that non-immunity genes that interact with viral
genes nef, tat and vpr also show significantly elevated expression
variability. This observation might help expand the list of
candidate genes that reduce HIV susceptibility. From an
evolutionary perspective, our observation might also suggest that
the virus can increase the chance of survival by preferentially
targeting variable host factors.
Materials and Methods
Processing gene expression data
The recently released whole-genome expression profiling of 270
HapMap individuals spanning 4 ethnic populations in the
lymphoblastoid cell line [2,20], includes CHB (Chinese Han in
Beijing), YRI (Yoruba people of Ibadan, Nigeria), CEU (U.S.
residents with northern and western European ancestry) and JPT
(Japanese from Tokyo). Using an Illumina annotation table, we
unambiguously mapped 18,127 utilized probes to human mRNA
transcripts (only those with RefSeq NM_ identifiers). We then
removed the 10% of genes with the lowest expression level
(assuming they are not expressed in the lymphoblastoid cell line).
The Illumina-annotated gene symbols were mapped onto officially
approved HGNC (HUGO Gene Nomenclature Committee)
symbols, allowing us to retain a total of 15, 554 unique HGNC
genes. We filtered out Y-linked genes, and included both male and
female samples in this study since sex-biased expression is minimal
(even for X-linked genes) in the lymphoblastoid cell line [20]. We
separated expression data of adult children from the unrelated
parents because the trio family data might bring unnecessary
dependency between data points because of parent-child inheri-
tance in gene expression [2]. Finally we were able to retain 18,081
mRNA transcripts and 15,501 HGNC genes for each of the 30
individuals in both CEU and YRI populations. In addition, we
were also concerned with the potential bias caused by the presence
of SNPs on the designed microarray probes; however, after
mapping the ,3 million annotated HapMap SNPs onto the 18,
081 Illumina probes, we found the influence is minimal as ,95%
of the probes was not affected.
We used the same expression data as above to identify
differentially expressed genes, but the data were median-
normalized across composite population by pooling all populations
together. This is of vital importance in differential expression
analysis because in this way we could normalize the expression
profiles of CEU and YRI using the same background scale. By
excluding genes showing population-specific variability, we were
able to consider 16, 878 transcripts in differential expression
analysis.
HIV-1, human protein interaction
We downloaded the annotated HIV-1, human protein interac-
tions from NCBI (http://www.ncbi.nlm.nih.gov/RefSeq/
HIVInteractions/) [27]. We considered human genes having
‘‘all’’ interactions with each of the nine HIV-1 genes, and mapped
the Entrez ID to RefSeq mRNA IDs by using the DAVID ID
conversion tool [26]. After overlapping with the transcripts in our
study, we were able to consider 700, 194, 235, 211, 73, 853, 83,
215 and 30 transcripts interacting with HIV-1 genes env, gag, nef,
pol, rev, tat, vif, vpr and vpu, respectively.
Detecting outlier genes by regression analysis for gene
expression variability
To identify genes with population-specific expression variability
within CEU and YRI, we regressed expression fluctuation, g,i n
YRI and in CEU reciprocally and derived two lists of genes
showing population-specific variation by using CEU and YRI as
explanatory variables, respectively. About ,70% of the genes on
one list also appear on another list. The liner model was derived by
minimizing the square errors between the observed g and the
predicted values (^ g g). Taking YRI as an example, the residues,
r~gYRI{^ g gYRI, were then normalized and Studentized. For each
gene, by fitting a t-distribution, we calculated 95% confidence
intervals (CIs) of its residue, and the outliers were defined as the
genes away from the calculated 95% CIs of the fitted t-distribution.
Extracting annotated promoter, 59 UTR and 39 UTRs for
human genes
We extracted promoter sequences (annotate by UCSC Genome
Browser as upstream 1kb regions from transcription start site),
59UTR, and 39UTRs for both outlier genes and all annotated
human genes in UCSC.
Identifying genes showing differential expression
Our protocol is similar as described in [15], in which we
performed 10, 000 permutation t-test followed by Benjamini and
Hochberg FDR correction.
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